KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bio-Rad Laboratories (BIO) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $27.3 million.

  • Bio-Rad Laboratories' Shares Outstanding (Diluted Average) fell 330.69% to $27.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $27.3 million, marking a year-over-year decrease of 330.69%. This contributed to the annual value of $27.3 million for FY2025, which is 330.69% down from last year.
  • Bio-Rad Laboratories' Shares Outstanding (Diluted Average) amounted to $27.3 million in Q4 2025, which was down 330.69% from $27.4 million recorded in Q3 2025.
  • In the past 5 years, Bio-Rad Laboratories' Shares Outstanding (Diluted Average) registered a high of $30.2 million during Q3 2021, and its lowest value of $27.3 million during Q4 2025.
  • In the last 5 years, Bio-Rad Laboratories' Shares Outstanding (Diluted Average) had a median value of $29.4 million in 2023 and averaged $29.1 million.
  • In the last 5 years, Bio-Rad Laboratories' Shares Outstanding (Diluted Average) grew by 28.87% in 2021 and then tumbled by 406.76% in 2024.
  • Over the past 5 years, Bio-Rad Laboratories' Shares Outstanding (Diluted Average) (Quarter) stood at $30.2 million in 2021, then dropped by 1.4% to $29.8 million in 2022, then decreased by 1.93% to $29.2 million in 2023, then dropped by 3.41% to $28.2 million in 2024, then dropped by 3.31% to $27.3 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $27.3 million in Q4 2025, compared to $27.4 million in Q3 2025 and $27.6 million in Q2 2025.